New Delhi [India]: The World Health Organisation’s (WHO) approval for Bharat Biotech’s COVID-19 vaccine, Covaxin, is expected this week, sources said on Monday.
Bharat Biotech has submitted its Phase 3 clinical trials data that demonstrated 77.8 per cent efficacy to the Subject Expert Committee (SEC) of the Central Drugs Standard Control Organisation (CDSCO). Earlier in June, a pre-submission meeting for WHO Emergency Use Listing Procedure (EUL), which provides advice before the submission of the final dossier, was also held.
Union Health Minister Mansukh Mandaviya had also earlier met WHO Chief Scientist Dr Soumya Swaminathan and held discussions over the approval of Bharat Biotech’s Covid-19 vaccine Covaxin.
Marianne Simao, a WHO assistant director general for vaccines, also said that the UN health agency’s assessment of this vaccine was quite advanced and officials hoped for decision by mid-September.
Covaxin was developed by Hyderabad-based Bharat Biotech in association with the Indian Council of Medical Research and the National Institute of Virology. Covaxin, which has been developed in collaboration with the Indian Council of Medical Research (ICMR), contains a whole virion inactivated SARS-CoV-2 vaccine, which is produced in Vero cells. The vaccine is stable at 2 degrees Celsius to 8 degrees Celsius (refrigerated) and is shipped in a ready-to-use liquid formulation that permits distribution using existing vaccine supply chain channels.
The WHO has approved COVID-19 vaccines by Pfizer-BioNTech, AstraZeneca, Johnson and Johnson, Moderna and Sinopharm.
Must Read
- WHO to give approval to Covaxin this month, say top health…
- Germany will take next step after WHO's approval of Covaxin,…
- Covaxin gets emergency approval for children aged 2-18 years
- Approval for Covaxin on basis of WHO meeting today: Mansukh…
- WHO EUL approval opens up Covaxin for worldwide use, says…
- Bharat Biotech's partner seeks Covaxin approval in US for…
- Centre to launch Vaccine tracker giving week-by-week update…
- CDC panel endorses approval of the Pfizer Covid vaccine for…
- Zydus Cadila to seek approval for two-dose regimen of its…
- AstraZeneca to seek US approval for COVID-19 vaccine later…